Chengli Ling

530 total citations
9 papers, 439 citations indexed

About

Chengli Ling is a scholar working on Neurology, Molecular Biology and Biomaterials. According to data from OpenAlex, Chengli Ling has authored 9 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Neurology, 3 papers in Molecular Biology and 3 papers in Biomaterials. Recurrent topics in Chengli Ling's work include Nanoparticle-Based Drug Delivery (3 papers), Traditional Chinese Medicine Analysis (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Chengli Ling is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Traditional Chinese Medicine Analysis (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Chengli Ling collaborates with scholars based in China and South Korea. Chengli Ling's co-authors include Jing Qin, Jianming Liang, Jianxin Wang, Ying Zhu, Weigen Lu, Chun Zhang, Zhekang Cheng, Ruixiang Li, Caifang Gao and Qi Wang and has published in prestigious journals such as ACS Applied Materials & Interfaces, Molecules and Theranostics.

In The Last Decade

Chengli Ling

8 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengli Ling China 8 215 107 95 95 44 9 439
Zhekang Cheng China 6 289 1.3× 120 1.1× 50 0.5× 105 1.1× 33 0.8× 6 531
Ruiyang Ma China 7 134 0.6× 90 0.8× 74 0.8× 133 1.4× 32 0.7× 10 461
Mehdi Sanati Iran 15 238 1.1× 122 1.1× 41 0.4× 123 1.3× 35 0.8× 35 600
Weiping Zheng China 12 266 1.2× 50 0.5× 86 0.9× 50 0.5× 35 0.8× 24 619
Yuanjun Zhu China 12 177 0.8× 41 0.4× 106 1.1× 42 0.4× 32 0.7× 27 520
Weigen Lu China 13 260 1.2× 222 2.1× 146 1.5× 162 1.7× 48 1.1× 29 768
Yingjia Yao China 14 333 1.5× 61 0.6× 77 0.8× 52 0.5× 37 0.8× 22 622
Amira Sayed Hanafy Egypt 10 164 0.8× 124 1.2× 57 0.6× 75 0.8× 42 1.0× 18 596

Countries citing papers authored by Chengli Ling

Since Specialization
Citations

This map shows the geographic impact of Chengli Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengli Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengli Ling more than expected).

Fields of papers citing papers by Chengli Ling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengli Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengli Ling. The network helps show where Chengli Ling may publish in the future.

Co-authorship network of co-authors of Chengli Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Chengli Ling. A scholar is included among the top collaborators of Chengli Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengli Ling. Chengli Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ling, Chengli, Linglong Chen, Jianming Liang, et al.. (2025). Neutrophil/monocyte-targeted dual-ligands modified liposomes delivering puerarin for ischemia stroke treatment. Materials Today Bio. 33. 102077–102077.
2.
Ling, Chengli, Chang Lei, Xiong Cai, et al.. (2020). Neuroprotective effect of apigenin against cerebral ischemia/reperfusion injury. Journal of International Medical Research. 48(9). 1220745411–1220745411. 23 indexed citations
3.
Gao, Caifang, Jianming Liang, Ying Zhu, et al.. (2019). Menthol-modified casein nanoparticles loading 10-hydroxycamptothecin for glioma targeting therapy. Acta Pharmaceutica Sinica B. 9(4). 843–857. 61 indexed citations
4.
Liang, Jianming, Ying Zhu, Caifang Gao, et al.. (2019). Menthol-modified BSA nanoparticles for glioma targeting therapy using an energy restriction strategy. NPG Asia Materials. 11(1). 32 indexed citations
5.
Cheng, Zhekang, Meng Zhang, Chengli Ling, et al.. (2019). Neuroprotective Effects of Ginsenosides against Cerebral Ischemia. Molecules. 24(6). 1102–1102. 87 indexed citations
6.
Liang, Jianming, Caifang Gao, Ying Zhu, et al.. (2018). Natural Brain Penetration Enhancer-Modified Albumin Nanoparticles for Glioma Targeting Delivery. ACS Applied Materials & Interfaces. 10(36). 30201–30213. 54 indexed citations
7.
Ling, Chengli, Jianming Liang, Chun Zhang, et al.. (2018). Synergistic Effects of Salvianolic Acid B and Puerarin on Cerebral Ischemia Reperfusion Injury. Molecules. 23(3). 564–564. 46 indexed citations
8.
Liang, Jianming, Ruixiang Li, Yuwei He, et al.. (2018). A novel tumor-targeting treatment strategy uses energy restriction via co-delivery of albendazole and nanosilver. Nano Research. 11(9). 4507–4523. 22 indexed citations
9.
Zhang, Chun, Chengli Ling, Liang Pang, et al.. (2017). Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles. Theranostics. 7(13). 3260–3275. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026